Search Browse Earnings

BIOLARGO, INC.

OTC:BLGO

Chemicals & Allied Products·WESTMINSTER, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

BIOLARGO, INC. — SlamSEC

Revenue

$12.2M

+4250.7% YoY

FY 2023

Adj. EBITDA

-$4.3M

-35.2% margin

FY 2025

Net Income

-$2.5M

-20.7% margin

FY 2014

EPS (Diluted)

-$0.01

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$3.5M

FY 2025

Total Debt

$337,000

FY 2023

Net Cash

$3.2M

FY 2023

Enterprise Value

—

Debt / EBITDA

0.7x

FY 2023

EV / EBITDA

—

Employees

—

CFO

Dargan Charles K